Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
- Conditions
- Ischemic Heart DiseaseCoronary Artery DiseaseCoronary AtherosclerosisCoronary Artery Stenosis
- Interventions
- Procedure: CTO coronary angioplastyDrug: Optimal medicamentous treatmentProcedure: Stress-MRI
- Registration Number
- NCT02769650
- Lead Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Brief Summary
The hypothesis of this study is that Stress-MRI is a clinically significant method of myocardial perfusion assessment after coronary angioplasty with stenting of right coronary artery (RCA) chronic total occlusion (CTO) is performed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
- Stable angina, CCS FC II-IV
- "Right-dominance" coronary circulation according to coronary angiography
- Absence of other significant atherosclerotic coronary lesions (more than 65%)
- High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)
- Signed, documented informed consent prior to admission to the study
- Acute coronary syndrome
- Contraindications for adenosine stress test
- Low and moderate risk of myocardium ischemia according to stress-MRI data (perfusion defect in less than 2 segments in the area of interest)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Stress-MRI + Chronic total occlusion PCI CTO coronary angioplasty Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO Stress-MRI + Chronic total occlusion PCI Stress-MRI Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO Stress-MRI + Optimal medicamentous treatment Optimal medicamentous treatment Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment Stress-MRI + Optimal medicamentous treatment Stress-MRI Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment
- Primary Outcome Measures
Name Time Method Stress-MRI evaluation Within 2 and 12 month after hospitalization High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)
- Secondary Outcome Measures
Name Time Method Major adverse cardiac and cerebrovascular events (MACCE) During 1 year after first stress-MRI assessment Major adverse cardiac and cerebrovascular events (MACCE) including: All-cause mortality, Myocardial infarction, Stroke, Stent thrombosis, Clinically indicated Target lesion revascularization, Any target lesion revascularization, Any target vessel revascularization.
Stress-MRI evaluation (2) Within 2 and 12 month after hospitalization Dynamics of perfusion in myocardium scar tissue according to stress-MRI data
Clinical assessment Within 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 moths after hospitalization Dynamical assessment of stable angina FC (CCS) and dyspnea FC (NYHA)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
State Research Institute of CIrculation Pathology
🇷🇺Novosibirsk, Russian Federation